Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Equity Average (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Equity Average for 3 consecutive years, with $226.0 million as the latest value for Q1 2026.

  • Quarterly Equity Average rose 191.43% to $226.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $226.0 million through Jan 2026, up 191.43% year-over-year, with the annual reading at -$2.0 million for FY2025, N/A changed from the prior year.
  • Equity Average for Q1 2026 was $226.0 million at Kestra Medical Technologies, up from $174.1 million in the prior quarter.
  • The five-year high for Equity Average was $226.0 million in Q1 2026, with the low at -$247.2 million in Q1 2025.
  • Average Equity Average over 3 years is -$39.5 million, with a median of -$112.3 million recorded in 2024.
  • Peak annual rise in Equity Average hit 191.48% in 2025, while the deepest fall reached 86.77% in 2025.
  • Over 3 years, Equity Average stood at -$226.5 million in 2024, then skyrocketed by 176.87% to $174.1 million in 2025, then increased by 29.82% to $226.0 million in 2026.
  • According to Business Quant data, Equity Average over the past three periods came in at $226.0 million, $174.1 million, and $194.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.